# Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity

> **NCT06405737** · NA · COMPLETED · sponsor: **University of Electronic Science and Technology of China** · enrollment: 80 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Intranasal oxytocin
- **DRUG:** Intranasal placebo

## Key facts

- **NCT ID:** NCT06405737
- **Lead sponsor:** University of Electronic Science and Technology of China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-07
- **Primary completion:** 2024-06-12
- **Final completion:** 2024-06-20
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06405737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06405737, "Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06405737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*